Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 169

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Transcriptional and translational regulation of BACE1 expression—Implications for Alzheimer's disease

Roßner, Steffen, Sastre, Magdalena, Bourne, Krystyn, Lichtenthaler, Stefan F. · 2006 · Progress in Neurobiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pneurobio.2006.06.001

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 151

  1. Aisen, 2003, Effects of rofecoxib or naproxen vs. placebo on Alzheimer disease progression: a randomized controlled trial, JAMA, 289, 2819, 10.1001/jama.289.21.2819 · DOI · Paper page
  2. Allinson, 2003, ADAMs family members as amyloid precursor protein alpha-secretases, J. Neurosci. Res., 74, 342, 10.1002/jnr.10737 · DOI · Paper page
  3. Ammendola, 1992, Sp1 DNA binding efficiency is highly reduced in nuclear extracts from aged rat tissues, J. Biol. Chem., 267, 17944, 10.1016/S0021-9258(19)37134-0 · DOI
  4. Apelt, 2004, Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology, Int. J. Dev. Neurosci., 22, 475, 10.1016/j.ijdevneu.2004.07.006 · DOI · Paper page
  5. Arendt, 2003, Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the ‘Dr. Jekyll and Mr. Hyde concept’ of Alzheimer's disease or the yin and yang of neuroplasticity, Prog. Neurobiol., 71, 83, 10.1016/j.pneurobio.2003.09.007 · DOI · Paper page
  6. Basha, 2005, The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain, J. Neurosci., 25, 823, 10.1523/JNEUROSCI.4335-04.2005 · DOI · Paper page
  7. Bigl, 2000, Expression of beta-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology, Neurosci. Lett., 292, 107, 10.1016/S0304-3940(00)01452-X · DOI
  8. Blasko, 2001, Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells, Neurobiol. Dis., 8, 1094, 10.1006/nbdi.2001.0451 · DOI
  9. Blasko, 2004, Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer's disease beta-secretase (BACE-1), J. Neural Transm., 111, 523, 10.1007/s00702-003-0095-6 · DOI · Paper page
  10. Bodendorf, 2001, A splice variant of beta-secretase deficient in the amyloidogenic processing of the amyloid precursor protein, J. Biol. Chem., 276, 12019, 10.1074/jbc.M008861200 · DOI · Paper page
  11. Bourne, K.Z., Lange-Dohna, C., Roßner, S., Perez-Polo, J.R., in press. Rat BACE1 promoter nuclear factor-κB binding characterization. J. Neurosci. Res.
  12. Breidert, 2002, Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease, J. Neurochem., 82, 615, 10.1046/j.1471-4159.2002.00990.x · DOI · Paper page
  13. Buxbaum, 1998, Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor, J. Biol. Chem., 273, 27765, 10.1074/jbc.273.43.27765 · DOI · Paper page
  14. Cai, 2001, BACE1 is the major beta-secretase for generation of Abeta peptides by neurons, Nat. Neurosci., 4, 233, 10.1038/85064 · DOI · Paper page
  15. Camacho, 2004, Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide, J. Neurosci., 24, 10908, 10.1523/JNEUROSCI.3987-04.2004 · DOI · Paper page
  16. Camandola, 2000, The lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons, Mol. Brain Res., 85, 53, 10.1016/S0169-328X(00)00234-5 · DOI
  17. Campbell, 2004, Post-translational modification of RelA(p65) NF-kappaB, Biochem. Soc. Trans., 32, 1087, 10.1042/BST0321087 · DOI
  18. Cao, 2001, A transcriptively active complex of APP with Fe65 and histone acetyltransferase tip60, Science, 293, 115, 10.1126/science.1058783 · DOI · Paper page
  19. Chernak, 1997, Interaction of nuclear factors from young and old rat brain regions with regulatory sequences of the D2 dopamine receptor gene promoter, Mol. Brain Res., 44, 113, 10.1016/S0169-328X(96)00197-0 · doi:10.1016/s0169-328x(96)00197-0
  20. Christensen, 2004, Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1, Mol. Cell Biol., 24, 865, 10.1128/MCB.24.2.865-874.2004 · DOI · Paper page
  21. Citron, 2004, beta-Secretase inhibition for the treatment of Alzheimer's disease—promise and challenge, Trends Pharmacol. Sci., 25, 92, 10.1016/j.tips.2003.12.004 · DOI · Paper page
  22. Citron, 1995, Generation of amyloid beta protein from its precursor is sequence specific, Neuron, 14, 661, 10.1016/0896-6273(95)90323-2 · DOI · Paper page
  23. Clemens, 1999, Translational control: the cancer connection, Int. J. Biochem. Cell Biol., 31, 1, 10.1016/S1357-2725(98)00127-7 · DOI · Paper page
  24. Combs, 2000, Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists, J. Neurosci., 20, 558, 10.1523/JNEUROSCI.20-02-00558.2000 · DOI · Paper page
  25. Cunard, 2002, Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors, J. Immunol., 168, 2795, 10.4049/jimmunol.168.6.2795 · DOI · Paper page
  26. d’Abramo, 2005, Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death, Biochem. J., 391, 693, 10.1042/BJ20050560 · DOI
  27. Daynes, 2002, Emerging roles of PPARs in inflammation and immunity, Nat. Rev. Immunol., 2, 748, 10.1038/nri912 · DOI · Paper page
  28. Dehmer, 2004, Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation, J. Neurochem., 88, 494, 10.1046/j.1471-4159.2003.02210.x · DOI · Paper page
  29. De Pietri Tonelli, 2004, Translational regulation of BACE-1 expression in neuronal and non-neuronal cells, Nucleic Acids Res., 32, 1808, 10.1093/nar/gkh348 · DOI
  30. Dermaut, 2005, Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum, Trends Genet., 21, 664, 10.1016/j.tig.2005.09.005 · DOI
  31. De Strooper, 2000, Proteolytic processing and cell biological functions of the amyloid precursor protein, J. Cell Sci., 113, 1857, 10.1242/jcs.113.11.1857 · DOI · Paper page
  32. Diab, 2002, Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis, J. Immunol., 168, 2508, 10.4049/jimmunol.168.5.2508 · DOI · Paper page
  33. Donohoe, 1999, Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality, Mol. Cell Biol., 19, 7237, 10.1128/MCB.19.10.7237 · DOI · Paper page
  34. Dunah, 2002, Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease, Science, 296, 2238, 10.1126/science.1072613 · DOI · Paper page
  35. Farber, 1995, Regulated secretion of β-amyloid precursor protein in rat brain, J. Neurosci., 15, 7442, 10.1523/JNEUROSCI.15-11-07442.1995 · DOI · Paper page
  36. Farzan, 2000, BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein, Proc. Natl. Acad. Sci. U.S.A., 97, 9712, 10.1073/pnas.160115697 · DOI · Paper page
  37. Feinstein, 2002, Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis, Ann. Neurol., 51, 694, 10.1002/ana.10206 · DOI · Paper page
  38. Fuentealba, 2004, Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease, Brain Res. Rev., 47, 275, 10.1016/j.brainresrev.2004.07.018 · DOI
  39. Fukumoto, 2002, Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease, Arch. Neurol., 59, 1381, 10.1001/archneur.59.9.1381 · DOI · Paper page
  40. Gau, 2002, Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice, Am. J. Pathol., 160, 731, 10.1016/S0002-9440(10)64893-6 · DOI
  41. Gimble, 1996, Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells, Mol. Pharmacol., 50, 1087
  42. Glasgow, 2000, One path to cell death in the nervous system, Neurochem. Res., 25, 1373, 10.1023/A:1007612716591 · DOI
  43. Glenner, 1984, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
  44. Gordon, 2003, Yin Yang 1 is a lipopolysaccharide-inducible activator of the murine 3′ Igh enhancer, hs3, J. Immunol., 170, 5549, 10.4049/jimmunol.170.11.5549 · DOI
  45. Grilli, 1995, Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene, J. Biol. Chem., 270, 26774, 10.1074/jbc.270.45.26774 · DOI
  46. Gruninger-Leitch, 2002, Substrate and inhibitor profile of BACE (beta-secretase) and comparison with other mammalian aspartic proteases, J. Biol. Chem., 277, 4687, 10.1074/jbc.M109266200 · DOI · Paper page
  47. Haass, 2004, Take five—BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation, EMBO J., 23, 483, 10.1038/sj.emboj.7600061 · DOI · Paper page
  48. Haass, 1993, b-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms, J. Biol. Chem., 268, 3021, 10.1016/S0021-9258(18)53650-4 · DOI · Paper page
  49. Hahn, 1992, Cloning of the rat gene encoding choline acetyltransferase, a cholinergic neuron-specific marker, Proc. Natl. Acad. Sci. U.S.A., 89, 4387, 10.1073/pnas.89.10.4387 · DOI
  50. Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
  51. Hartlage-Rübsamen, 2003, Astrocytic expression of the Alzheimer's disease β-secretase (BACE) is stimulus-dependent, Glia, 41, 169, 10.1002/glia.10178 · DOI · Paper page
  52. Higgins, 1996, P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain, Am. J. Pathol., 149, 585
  53. Hirano, 1998, Functional interference of Sp1 and NF-kappaB through the same DNA binding site, Mol. Cell Biol., 18, 1266, 10.1128/MCB.18.3.1266 · DOI
  54. Hiromura, 2003, YY1 is regulated by O-linked N-acetylglucosaminylation (O-glcNAcylation), J. Biol. Chem., 278, 14046, 10.1074/jbc.M300789200 · DOI
  55. Hoffman, 1995, DNA binding and regulatory effects of transcription factors SP1 and USF at the rat amyloid precursor protein gene promoter, Nucleic Acids Res., 23, 2229, 10.1093/nar/23.12.2229 · DOI
  56. Hoshi, 1997, Nontoxic amyloid β peptide (1-42) supresses acetylcholine synthesis—possible role in cholinergic dysfunction in Alzheimer's disease, J. Biol. Chem., 272, 2038, 10.1074/jbc.272.4.2038 · DOI
  57. Hsiao, 1996, Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 · DOI · Paper page
  58. Hussain, 1999, Identification of a novel aspartic protease (Asp 2) as beta-secretase, Mol. Cell. Neurosci., 14, 419, 10.1006/mcne.1999.0811 · DOI · Paper page
  59. Hyde-DeRuyscher, 1995, DNA binding sites for the transcriptional activator/repressor YY1, Nucleic Acids Res., 23, 4457, 10.1093/nar/23.21.4457 · DOI · Paper page
  60. Inoue, 1993, Enhancer containing unusual GC box-like sequences on the human choline acetyltransferase gene, Mol. Brain Res., 20, 299, 10.1016/0169-328X(93)90056-U · DOI
  61. Irizarry, 2001, Beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging, Am. J. Pathol., 158, 173, 10.1016/S0002-9440(10)63955-7 · DOI
  62. Jiang, 1998, PPAR-γ agonists inhibit production of monocyte inflammatory cytokines, Nature, 391, 82, 10.1038/35154 · DOI · Paper page
  63. Jones, 2003, Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?, Int. J. Geriatr. Psychiatry, 18, S7, 10.1002/gps.936 · DOI · Paper page
  64. Jope, 1996, Cholinergic muscarinic receptor signaling by the phosphoinositide signal transduction system in Alzheimer's disease, Alzheimer's Dis. Rev., 1, 2
  65. Jope, 1997, Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain, Neurobiol. Aging, 18, 111, 10.1016/S0197-4580(96)00205-9 · DOI
  66. Joseph, 2001, Copernicus revisited: amyloid beta in Alzheimer's disease, Neurobiol. Aging, 22, 131, 10.1016/S0197-4580(00)00211-6 · DOI · Paper page
  67. Kaltschmidt, 1997, Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 94, 2642, 10.1073/pnas.94.6.2642 · DOI · Paper page
  68. Kaltschmidt, 1999, Inhibition of NF-κB potentiates amyloid-β-mediated neuronal apoptosis, Proc. Natl. Acad. Sci. U.S.A., 96, 9409, 10.1073/pnas.96.16.9409 · DOI · Paper page
  69. Kaltschmidt, 1745, Signaling via NF-kappaB in the nervous system, Biochim. Biophys. Acta, 287
  70. Kar, 1996, β-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices, J. Neurosci., 16, 1034, 10.1523/JNEUROSCI.16-03-01034.1996 · DOI
  71. Kelly, 1996, Amyloid β peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons, Proc. Natl. Acad. Sci. U.S.A., 93, 6753, 10.1073/pnas.93.13.6753 · DOI · Paper page
  72. Kitazume, 2005, In vivo cleavage of alpha2,6-sialyltransferase by Alzheimer beta-secretase, J. Biol. Chem., 280, 8589, 10.1074/jbc.M409417200 · DOI · Paper page
  73. Kitazume, 2003, Characterization of alpha 2,6-sialyltransferase cleavage by Alzheimer's beta-secretase (BACE1), J. Biol. Chem., 278, 14865, 10.1074/jbc.M206262200 · DOI
  74. Kitazume, 2001, Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase, Proc. Natl. Acad. Sci. U.S.A., 98, 13554, 10.1073/pnas.241509198 · DOI · Paper page
  75. Koike, 1999, Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein, Biochem. J., 343, 371, 10.1042/0264-6021:3430371 · doi:10.1042/0264-6021:3430371 · Paper page
  76. Koo, 1994, Evidence that production and release of amyloid beta-protein involves the endocytic pathway, J. Biol. Chem., 269, 17386, 10.1016/S0021-9258(17)32449-3 · DOI · Paper page
  77. Korhonen, 1997, Glutamate-induced changes in the DNA-binding complexes of transcription factor YY1 in cultured hippocampal and cerebellar granule cells, Mol. Brain Res., 52, 330
  78. Korhonen, 2005, Changes in DNA binding pattern of transcription factor YY1 in neuronal degeneration, Neurosci. Lett., 377, 121, 10.1016/j.neulet.2004.11.085 · DOI
  79. Kozak, 1987, An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs, Nucleic Acids Res., 15, 8125, 10.1093/nar/15.20.8125 · DOI · Paper page
  80. Krabbe, 2004, Inflammatory mediators in the elderly, Exp. Gerontol., 39, 687, 10.1016/j.exger.2004.01.009 · DOI · Paper page
  81. Krippner-Heidenreich, 2005, Caspase-dependent regulation and subcellular redistribution of the transcriptional modulator YY1 during apoptosis, Mol. Cell Biol., 25, 3704, 10.1128/MCB.25.9.3704-3714.2005 · DOI
  82. Kukar, 2005, Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production, Nat. Med., 11, 545, 10.1038/nm1235 · DOI · Paper page
  83. Kwon, 2003, Yin Yang 1, a vertebrate polycomb group gene, regulates antero-posteriorneural patterning, Biochem. Biophys. Res. Commun., 306, 1008, 10.1016/S0006-291X(03)01071-4 · DOI
  84. Lahiri, 1991, The promoter activity of the gene encoding Alzheimer beta-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences, Mol. Brain Res., 9, 253, 10.1016/0169-328X(91)90009-M · DOI
  85. Lalowski, 1996, The “nonamyloidogenic” p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid, J. Biol. Chem., 271, 33623, 10.1074/jbc.271.52.33623 · DOI
  86. Lammich, 1999, Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease, Proc. Natl. Acad. Sci. U.S.A., 96, 3922, 10.1073/pnas.96.7.3922 · DOI · Paper page
  87. Lammich, 2004, Expression of the Alzheimer protease BACE1 is suppressed via its 5′-untranslated region, EMBO Rep., 5, 620, 10.1038/sj.embor.7400166 · DOI
  88. Lange-Dohna, 2003, Cloning and expression of the rat BACE1 promoter, J. Neurosci. Res., 73, 73, 10.1002/jnr.10639 · DOI
  89. Leuba, 2005, Neuronal and nonneuronal quantitative BACE immunocytochemical expression in the entorhinohippocampal and frontal regions in Alzheimer's disease, Dement. Geriatr. Cogn. Disord., 19, 171, 10.1159/000083496 · DOI
  90. Li, 2000, Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice, J. Clin. Invest., 106, 523, 10.1172/JCI10370 · DOI · Paper page
  91. Li, 2004, Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE1, J. Biol. Chem., 279, 10542, 10.1074/jbc.M310001200 · DOI · Paper page
  92. Li, 1991, Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription, Cell, 65, 493, 10.1016/0092-8674(91)90467-D · DOI · Paper page
  93. Li, 2002, Interaction of Huntington disease protein with transcriptional activator Sp1, Mol. Cell Biol., 22, 1277, 10.1128/MCB.22.5.1277-1287.2002 · DOI · Paper page
  94. Li, 2006, Control of APP processing and Abeta generation level by BACE1 enzymatic activity and transcription, FASEB J., 20, 285, 10.1096/fj.05-4986com · DOI
  95. Lichtenthaler, 2003, The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1, J. Biol. Chem., 278, 48713, 10.1074/jbc.M303861200 · DOI · Paper page
  96. Lin, 2000, Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein, Proc. Natl. Acad. Sci. U.S.A., 97, 1456, 10.1073/pnas.97.4.1456 · DOI · Paper page
  97. Liu, 2004, NF-kappaB site interacts with Sp factors and up-regulates the NR1 promoter during neuronal differentiation, J. Biol. Chem., 279, 17449, 10.1074/jbc.M311267200 · DOI
  98. Liu, 2002, Glu11 site cleavage and N-terminally truncated Abeta production upon BACE overexpression, Biochemistry, 41, 3128, 10.1021/bi015800g · DOI · Paper page
  99. Liu, 2002, Identification and functional analysis of the rat caspase-3 gene promoter, J. Biol. Chem., 277, 8273, 10.1074/jbc.M110768200 · DOI
  100. Lukiw, 1994, Protein–DNA interactions in the promoter region of the amyloid precursor protein (APP) gene in human neocortex, Mol. Brain Res., 22, 121, 10.1016/0169-328X(94)90039-6 · DOI
  101. Luo, 2003, BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time, Neurobiol. Dis., 14, 81, 10.1016/S0969-9961(03)00104-9 · DOI · Paper page
  102. Manzella, 1991, Insulin induction of ornithine decarboxylase. Importance of mRNA secondary structure and phosphorylation of eucaryotic initiation factors eIF-4B and eIF-4E, J. Biol. Chem., 266, 2383, 10.1016/S0021-9258(18)52255-9 · DOI · Paper page
  103. Marcinkiewicz, 2000, Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain, J. Neurochem., 75, 2133, 10.1046/j.1471-4159.2000.0752133.x · DOI · Paper page
  104. Mash, 1985, Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation, Science, 228, 1115, 10.1126/science.3992249 · DOI · Paper page
  105. Mitsuda, 1997, Transcriptional regulation of the mouse presenilin-1 gene, J. Biol. Chem., 272, 23489, 10.1074/jbc.272.38.23489 · DOI
  106. Niino, 2001, Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma, J. Neuroimmunol., 116, 40, 10.1016/S0165-5728(01)00285-5 · DOI · Paper page
  107. Nitsch, 1994, Role of neurotransmission in the regulation of amyloid beta-protein precursor processing, Biochem. Pharmacol., 47, 1275, 10.1016/0006-2952(94)90325-5 · DOI
  108. Nordberg, 1992, Neuroreceptor changes in Alzheimer's disease, Cerebrovasc. Brain Metab. Rev., 4, 303
  109. Nowak, 2006, The transcription factor Yin Yang1 is an activator of BACE1 expression, J. Neurochem., 96, 1696, 10.1111/j.1471-4159.2006.03692.x · DOI
  110. Oei, 2001, Transcription factor Yin Yang 1 stimulates poly(ADP-ribosyl)ation and DNA repair, Biochem. Biophys. Res. Commun., 284, 450, 10.1006/bbrc.2001.4985 · DOI
  111. Ohno, 2004, BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease, Neuron, 41, 27, 10.1016/S0896-6273(03)00810-9 · DOI · Paper page
  112. Palko, 2004, The Yin Yang-1 (YY1) protein undergoes a DNA-replication-associated switch in localization from the cytoplasm to the nucleus at the onset of S phase, J. Cell Sci., 117, 465, 10.1242/jcs.00870 · DOI
  113. Parks, 1996, The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1, J. Biol. Chem., 271, 4417, 10.1074/jbc.271.8.4417 · DOI · Paper page
  114. Pastorino, 2004, BACE (beta-secretase) modulates the processing of APLP2 in vivo, Mol. Cell. Neurosci., 25, 642, 10.1016/j.mcn.2003.12.013 · DOI
  115. Pennypacker, 1998, Cloning and characterization of the presenilin-2 gene promoter, Mol. Brain Res., 56, 57, 10.1016/S0169-328X(98)00028-X · DOI
  116. Perkins, 1993, A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation, EMBO J., 12, 3551, 10.1002/j.1460-2075.1993.tb06029.x · DOI · Paper page
  117. Pollwein, 1993, Overlapping binding sites of two different transcription factors in the promoter of the human gene for the Alzheimer amyloid precursor protein, Biochem. Biophys. Res. Commun., 190, 637, 10.1006/bbrc.1993.1096 · DOI
  118. Preece, 2003, Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease, Mol. Brain Res., 116, 155, 10.1016/S0169-328X(03)00233-X · DOI
  119. Puglielli, 2003, Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis, J. Biol. Chem., 278, 19777, 10.1074/jbc.M300466200 · DOI · Paper page
  120. Ricote, 1999, The peroxisome proliferator-activated receptor (PPARγ) as a regulator of monocyte/macrophage function, J. Leukocyte Biol., 66, 733, 10.1002/jlb.66.5.733 · DOI · Paper page
  121. Rogers, 2004, Differential utilization of upstream AUGs in the beta-secretase mRNA suggests that a shunting mechanism regulates translation, Proc. Natl. Acad. Sci. U.S.A., 101, 2794, 10.1073/pnas.0308576101 · DOI
  122. Roßner, 2001, Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology, J. Neurosci. Res., 64, 437, 10.1002/jnr.1095 · DOI
  123. Roßner, 1998, The regulation of APP metabolism by cholinergic mechanisms and neurotrophin receptor signaling, Prog. Neurobiol., 56, 541, 10.1016/S0301-0082(98)00044-6 · DOI · Paper page
  124. Sabo, 1999, Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein, J. Biol. Chem., 274, 7952, 10.1074/jbc.274.12.7952 · DOI · Paper page
  125. Sastre, 2003, Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase, J. Neurosci., 23, 9796, 10.1523/JNEUROSCI.23-30-09796.2003 · DOI · Paper page
  126. Sastre, 2006, NSAIDs repress BACE1 gene promoter activity by activation of the peroxisome proliferator-activated receptor-γ (PPARγ), Proc. Natl. Acad. Sci. U.S.A., 103, 443, 10.1073/pnas.0503839103 · DOI · Paper page
  127. Saunders, 1999, BACE Maps to Chromosome 11 and a BACE homolog, BACE2, reside in the obligate Down syndrome region of chromosome 21, Science, 286, 1255a, 10.1126/science.286.5443.1255a · DOI
  128. Selkoe, 2003, Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics, Ann. Rev. Pharmacol. Toxicol., 43, 545, 10.1146/annurev.pharmtox.43.100901.140248 · DOI · Paper page
  129. Shi, 1991, Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein, Cell, 67, 377, 10.1016/0092-8674(91)90189-6 · DOI · Paper page
  130. Sinha, 1999, Purification and cloning of amyloid precursor protein beta-secretase from human brain, Nature, 402, 537, 10.1038/990114 · DOI · Paper page
  131. Sun, 2002, Localization of beta-secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls, Exp. Neurol., 175, 10, 10.1006/exnr.2002.7875 · DOI
  132. Svensson, 1992, Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists, Brain Res., 596, 142, 10.1016/0006-8993(92)91541-L · DOI
  133. Tanahashi, 2001, Three novel alternatively spliced isoforms of the human beta-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid beta-peptide production, Neurosci. Lett., 307, 9, 10.1016/S0304-3940(01)01912-7 · DOI · Paper page
  134. Tohgi, 1999, The methylation status of cytosines in a tau gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex, Neurosci. Lett., 275, 89, 10.1016/S0304-3940(99)00731-4 · DOI
  135. Toliver-Kinsky, 2000, Nuclear factor kappaB/p49 is a negative regulatory factor in nerve growth factor-induced choline acetyltransferase promoter activity in PC12 cells, J. Neurochem., 75, 2241, 10.1046/j.1471-4159.2000.0752241.x · DOI
  136. Tyler, 2002, Alpha- and beta-secretase: profound changes in Alzheimer's disease, Biochem. Biophys. Res. Commun., 299, 373, 10.1016/S0006-291X(02)02635-9 · DOI · Paper page
  137. Watson, 2005, Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study, Am. J. Geriatr. Psychiatry, 13, 950
  138. Whitehouse, 1986, Cholinergic receptors in aging and Alzheimer's disease, Prog. Neuro-Psychopharmacol. Biol. Psychat., 10, 665, 10.1016/0278-5846(86)90035-7 · DOI
  139. Willis, 1999, Translational control of growth factor and proto-oncogene expression, Int. J. Biochem. Cell Biol., 31, 73, 10.1016/S1357-2725(98)00133-2 · DOI
  140. Wong, 2005, beta subunits of voltage-gated sodium channels are novel substrates of BACE1 and gamma-secretase, J. Biol. Chem., 280, 23009, 10.1074/jbc.M414648200 · DOI · Paper page
  141. Xing, 1997, TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression, Endocrinology, 138, 2776, 10.1210/en.138.7.2776 · DOI
  142. Yan, 2003, Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease, J. Neurosci., 23, 7504, 10.1523/JNEUROSCI.23-20-07504.2003 · DOI · Paper page
  143. Yan, 2001, BACE2 functions as an alternative alpha-secretase in cells, J. Biol. Chem., 276, 34019, 10.1074/jbc.M105583200 · DOI · Paper page
  144. Yasojima, 2001, Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain, Brain Res., 919, 115, 10.1016/S0006-8993(01)03008-6 · DOI · Paper page
  145. Yeh, 2003, Association of transcription factor YY1 with the high molecular weight Notch complex suppresses the transactivation activity of Notch, J. Biol. Chem., 278, 41963, 10.1074/jbc.M304353200 · DOI
  146. Zambrano, 1997, Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins, J. Biol. Chem., 272, 6399, 10.1074/jbc.272.10.6399 · DOI
  147. Zambrano, 1997, DNA-binding protein Pur alpha and transcription factor YY1 function as transcription activators of the neuron-specific FE65 gene promoter, Biochem. J., 328, 293, 10.1042/bj3280293 · DOI
  148. Zohar, 2003, Quantification and distribution of beta-secretase alternative splice variants in the rat and human brain, Mol. Brain Res., 115, 63, 10.1016/S0169-328X(03)00182-7 · DOI · Paper page
  149. Zohar, 2005, Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice, Neurobiol. Aging, 26, 1167, 10.1016/j.neurobiolaging.2004.10.005 · DOI · Paper page
  150. Zuchner, 2004, Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling, J. Neurosci. Res., 77, 250, 10.1002/jnr.20152 · DOI
  151. Zuchner, 2005, Down-regulation of muscarinic acetylcholine receptor M2 adversely affects the expression of Alzheimer's disease-relevant genes and proteins, J. Neurochem., 95, 20, 10.1111/j.1471-4159.2005.03335.x · DOI

Cited by

See all 169

Metadata

Authors
Roßner, S., Sastre, M., Bourne, K., & Lichtenthaler, S. F.
Venue
Progress in Neurobiology
Publisher
Elsevier BV
Published
2006-06
Volume
79
Issue
2
Pages
95-111
ISSN
0301-0082
Cited by
169
References
28
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.